Gynecology

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.

The FDA has issued a Complete Response Letter for the New Drug Application of cefepime-taniborbactam, requesting additional chemistry, manufacturing, and controls data.

Discover how immediate postoperative symptom burden varies between open and minimally invasive hysterectomies under enhanced recovery after surgery protocols, shedding light on recovery disparities in gynecologic surgery.

Recent research highlights the efficacy and safety of relugolix combination therapy in managing uterine fibroid-associated heavy menstrual bleeding specifically among Black women, demonstrating outcomes comparable to the broader population.

A comprehensive investigation uncovers the pervasive presence of endocrine-disrupting chemicals in menstrual hygiene items, potentially impacting gynecological and reproductive health.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study revealed an 8.47-fold increased risk of suicide attempts among individuals with polycystic ovary syndrome, prompting the need for proactive mental health management in patients and improved tools for assessing health-related quality-of-life.

Explore the potential benefits and considerations of utilizing intraurethral lidocaine jelly during urodynamic studies for bladder testing, as we delve into research findings on patient discomfort, voiding metrics, and diagnostic precision.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study revealed that allogeneic hematopoietic stem cell transplantation does not lead to disease relapse in patients with acute leukemia undergoing ovarian tissue transplantation.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent exposed the relationship between financial strain, underutilization of health care, and comorbidities, shedding light on the heightened risks.

A recent study revealed that physician awareness of patients' desired level of decision-making significantly enhances satisfaction, highlighting the importance of tailored approaches for women with pelvic floor disorders seeking patient-centered care.

The digital editor for Contemporary OB/GYN offers his thoughts on trends and news in women’s health this past year.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study unveiled a novel screening method, utilizing validated questionnaires to accurately identify myofascial urinary frequency syndrome in patients with lower urinary tract symptoms.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reveals that relugolix combination therapy demonstrates sustained reduction in menstrual bleeding volume for women with symptomatic uterine fibroids.

A recent study reveals heightened rates of concomitant bilateral salpingo-oophorectomy during benign hysterectomy in women with disabilities, shedding light on potential disparities and urging improved physician counseling and shared decision-making strategies.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, outlines treatment options for uterine fibroids in patients with different needs.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, discusses treatment paradigms which can help clinicians manage abnormal uterine bleeding in their patients.

Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.

Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.

A recent study in Microorganisms reveals that Metronidazole treatment failure in bacterial vaginosis is linked to elevated activated T- and dendritic-cell subsets, potentially heightening susceptibility to HIV.